Pluri Inc. Other Non-Current Liabilities
Pluri Inc. (PLUR) had Other Non-Current Liabilities of $380.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2020-11-05
- 2020-09-30: Other Liabilities, Noncurrent $380.00K.
- 2019-06-30: Other Liabilities, Noncurrent $381.00K.
- 2019-03-31: Other Liabilities, Noncurrent $705.00K.
- 2018-12-31: Other Liabilities, Noncurrent $765.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2020-09-30 | $380.00K 10-Q · filed 2020-11-05 |
| 2019-06-30 | $381.00K 10-K · filed 2020-09-10 |
| 2019-03-31 | $705.00K 10-Q · filed 2019-05-06 |
| 2018-12-31 | $765.00K 10-Q · filed 2019-02-06 |
| 2018-09-30 | $825.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $778.00K 10-K · filed 2019-09-12 |
| 2018-03-31 | $838.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $897.00K 10-Q · filed 2018-02-06 |
| 2017-09-30 | $869.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $929.00K 10-K · filed 2018-09-12 |
| 2017-03-31 | $920.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $980.00K 10-Q · filed 2017-02-08 |
| 2016-09-30 | $1.04M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $1.10M 10-K · filed 2017-09-07 |
| 2016-03-31 | $1.16M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.22M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $481.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $502.00K 10-K · filed 2016-09-07 |
| 2015-03-31 | $523.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $544.00K 10-Q · filed 2015-02-05 |
| 2014-09-30 | $566.00K 10-Q · filed 2014-11-06 |
| 2014-06-30 | $588.00K 10-K · filed 2015-09-09 |
| 2014-03-31 | $611.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $633.00K 10-Q · filed 2014-02-05 |
| 2013-09-30 | $657.00K 10-Q · filed 2013-11-05 |
| 2013-06-30 | $680.00K 10-K · filed 2014-09-11 |
| 2013-03-31 | $709.00K 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |